Crossmark

Implications of empirical testing and treatment for atypical bacteria in patients hospitalized with COVID, influenza, or RSV: a retrospective observational cohort study

Crossref DOI link: https://doi.org/10.1007/s10096-026-05405-8

Published Online: 2026-01-17

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Hønge, Bo Langhoff

Redder, Jacob

Greve, Thomas

Dalgaard, Lars Skov

Sørensen, Anita Rath

Ebdrup, Lotte

Mohey, Rajesh

Tarp, Britta

Holm, Mette

Østergaard, Lars

Storgaard, Merete
Funding

Funding for this research was provided by:

Aarhus University Hospital
License Information

Text and Data Mining valid from 2026-01-17

Version of Record valid from 2026-01-17
More Information

Article History

Received: 25 August 2025

Accepted: 4 January 2026

First Online: 17 January 2026

Declarations

:

: The authors declare no competing interests.

: The author reports no conflicts of interest in this work. The authors declare that AI was not used for the writing of this article.

: BLH and JR had full access to data and are guarantors for the data.

Document is current

Any future updates will be listed below